ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

WPCT Woodford Patient Capital Trust Plc

33.60
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Woodford Patient Capital Trust Plc LSE:WPCT London Ordinary Share GB00BVG1CF25 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 33.60 33.55 33.90 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Schroder UK Public Private Tst plc Oxford Nanopore Files Notice of Intention to Float (9926L)

16/09/2021 9:13am

UK Regulatory


Woodford Patient Capital (LSE:WPCT)
Historical Stock Chart


From Apr 2021 to Apr 2024

Click Here for more Woodford Patient Capital Charts.

TIDMSUPP

RNS Number : 9926L

Schroder UK Public Private Tst plc

16 September 2021

Schroder UK Public Private Trust plc (the "Company")

Oxford Nanopore Files Notice of Intention to Float

The Company (LSE: SUPP) is pleased to note that its portfolio company Oxford Nanopore Technologies Limited ("Oxford Nanopore") has today filed notice of its intention to float.

As part of the potential initial public offering ("IPO"), it is expected that the company will include a limited secondary offer. Final details on sizing will be made available when the final prospectus is published. While the Company remains highly confident of Oxford Nanopore's prospects to realise a strong IPO and generate continuous shareholder value, given the large position of Oxford Nanopore in the Company's portfolio (21.8% of its Net Asset Value as at 31 March 2021), the Company will seek to further diversify its portfolio through a partial realisation of its holding. The Company will use the proceeds from the partial realisation to invest in existing and new portfolio companies.

The Company's 3.7% stake in Oxford Nanopore was valued at GBP90.7 million as at 31 March 2021, an implied total equity value of GBP2.5bn. It is anticipated that the Company's AIFM will revalue the holding based on the trading price of Oxford Nanopore's shares, in line with the other quoted investments in the portfolio. The Company will release a further update once the pricing of Oxford Nanopore's IPO has been announced.

Enquiries:

Schroder Investment Management Limited

 
 Gareth Faith   Tel: 020 7658 
                         5264 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ITFLFMPTMTMBMLB

(END) Dow Jones Newswires

September 16, 2021 04:13 ET (08:13 GMT)

1 Year Woodford Patient Capital Chart

1 Year Woodford Patient Capital Chart

1 Month Woodford Patient Capital Chart

1 Month Woodford Patient Capital Chart

Your Recent History

Delayed Upgrade Clock